Reposar, Jhon Rey B.
HRN: 07-39-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/14/2023
02/24/2023
IV
150mg
Q24hrs
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes